Skip to main content
Funded Studies

Kalpana M. Merchant, PhD

CSO at Vincere Biosciences, Inc.

Location: Portland, OR United States

Dr. Kalpana Merchant has deep expertise in the neurobiology of chronic neurodegenerative and psychiatric disorders. She has nearly 25 years of experience in drug discovery and development with a special emphasis on translational strategies. She retired in March 2014 from Eli Lilly where she was the chief scientific officer for tailored therapeutics-neuroscience, accountable for strategies to deliver personalized therapies and associated biomarkers for the neuroscience portfolio.

Since 2014, Dr. Merchant has engaged with non-profit foundations and start-up pharmaceutical companies as an advisor. In 2018, she joined Vincere Biosciences as the chief scientific officer to help develop small molecules to slow the progression of Parkinson's disease.

Dr. Merchant received her PhD in neuropharmacology from the University of Utah in 1989. Following a postdoctoral fellowship at University of Washington, she remained at the institute as assistant professor of psychiatry. She joined Eli Lilly in 2003 after contributing to neuroscience drug discovery research at Pharmacia Corp. for ~10 years.


Associated Grants

  • Measurement of BMP and NAG Activity in CSF Samples

    2019


  • Discovery and Development of Parkin Activators as Therapies for Parkinson’s Disease

    2019


  • LRRK2 Effects on Neural Differentiation (Supplement 1)

    2011


  • Identification of Alpha-synuclein Molecular Forms Correlating with Clinicopathology of Parkinson's Disease

    2009


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.